IBM and Genomics England Forge New Partnership to Transform Patient Care

Share this post:

Genomics, the study of how your genes interact with the external world, is transforming how medical science works. England is leading the world in using this information in the healthcare system, enabling clinicians to bring these insights to determine the treatment for a particular patient – this is precision medicine. Understanding genomes can provide evidence to help diagnose disease more quickly and specifically, particularly in cancer and rare diseases. This understanding of disease is important to researchers working to develop new diagnostic tests and treatments – small changes in a genome can show how to target treatments to help more patients in future.

With the code of the human body written in our genes, genomics enables us to unveil the basis of disease, and understand different responses to treatment in a much more personalised way. As we move into this new era, Genomics England is one of the leading organisations around the world in driving this transformation and building the capability and technology to enable more evidence-based diagnostics and treatments for patients.

Genomics England and IBM are delighted to announce that IBM has been selected as a strategic technology partner for Genomics England over 18 months. Genomics England’s services are growing rapidly, providing researchers access to genomic datasets to enable scientific discovery. A technology provider was required to support this rapid expansion, enabling the consumption of AWS cloud services and AI capabilities. IBM will work with Genomics England in three key areas:

  • Refine the clinical user interface and enable swift access to genomic data stores: as the software development partner, IBM will work to accelerate improvements in genomic interpretation services for patients and support enhancements in data science and bioinformatics processes. IBM will ensure the clinician experience is effective, efficient and speeds the rollout to new, approved users through intuitive design.
  • Support adoption of cloud capabilities into a hybrid cloud: as Genomics England’s data sets and services grow, AWS cloud will allow rapid scalability to meet the needs of the many users of Genomics England’s data and interpretation services. Supporting the in-house team, IBM will bring a wealth of experience in AWS to ensure the security and automation of High-Performance Computing and Cloud services through this period of rapid growth.
  • Service management wrap: with increased consumers of services and a move towards providing seven days per week service, IBM will bring experience of running large-scale, stable, supportable and sustainable IT services to Genomics England.

IBM is committed to supporting Genomics England’s goals of enabling clinicians to provide world-leading diagnoses and treatments services to NHS patients and accelerating scientific discovery to transform care into the future.

Find out more about IBM Consulting.

Partner - Client Partner, UK & Ireland

More Healthcare stories
By Mark Restall on 18 July, 2024

Multi-Modal Intelligence Platform

Traditionally, data management systems provided only numerical or textual based business intelligence primarily for back-office users across finance, sales, customer management and supply chain. Today, we are increasingly seeing data management systems which drive key business functions requiring interrogation of multi-modal data sets from documents, presentations, images, videos to audio. This demands a more sophisticated […]

Continue reading

By Mark Restall and others on 16 July, 2024

The use of GenAI to Migrate and Modernise Organisational Core Programming Languages

GenAI is hugely powerful and supports a diversity of use cases by focusing on routine work – allowing people to focus time on value-add tasks, thus enhancing productivity. The focus of this use case is for an organisation which had previously focussed on a legacy set of tooling and programming languages and needed a way […]

Continue reading

By Michael Conway on 27 June, 2024

How Virgin Money is Humanising Digital Experiences with AI

Today, every company is selling a digital experience – and competition is fierce. Hyper-personalisation is the new high bar for success, as customers demand relevant suggestions and seamless service. But bespoke service is not enough. Customer experiences must also be intuitive, offering people something helpful without them having to ask for it. Generative AI is […]

Continue reading